Most recently, Arialys Therapeutics raised $14.8M in its Early Stage VC (Jun 2025).
- ·Watch Arialys Therapeutics: the Monday email on marks, rounds and moves
Arialys Therapeutics round by round
2 roundsHow much has Arialys Therapeutics raised?
Arialys Therapeutics has raised $72 million in total; 2 of its rounds are on record. The largest on record was a $14.8 million early-stage round in Jun 2025.
Arialys Therapeutics has filed 2 Form Ds with the SEC since 2022, most recently in Jul 2025 ($14.8 million sold to 7 investors).
Arialys Therapeutics investors
6 investors are on record for Arialys Therapeutics, including Alexandria Venture Investments, Johnson & Johnson JJDC, MPM BioImpact and Alexandria Real Estate Equities. The early-stage round in Jun 2025 drew 7 investors.
6 investors have backed Arialys Therapeutics.
Frequently asked about Arialys Therapeutics
- How much has Arialys Therapeutics raised?
- Arialys Therapeutics has raised $72.0M in total across 2 recorded funding rounds.
- When was Arialys Therapeutics's last funding round?
- Arialys Therapeutics's most recent recorded round was Early Stage VC in Jun 2025, raising $14.8M.